🔓
Sign in as a Member to unlock the full view of ABT. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
ABT

Abbott Laboratories

Sector: healthcareMedical - DevicesNYSEMarket Cap: $177.45B

Abbott Laboratories is a diversified global medical device, diagnostics, nutrition, and pharmaceutical company whose political exposure centers on FDA regulation, Medicare/Medicaid reimbursement, and healthcare policy.

Next filing → your inbox
Govt Dependence
55/100
Regulatory Density
78/100
Lobbying Intensity
35/100
Political Signal
MEDIUM

BusinessWhat ABT does

Abbott develops and sells medical devices (cardiovascular, diabetes care/continuous glucose monitors), diagnostics, branded generic pharmaceuticals, and nutrition products (Similac, Ensure). Revenue is diversified across these four segments with significant international exposure.

12 months past · 3 months futureABT activity timeline

$134$107$80 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $130.00 hi $82.56 lo $107.45 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 30 Ro Khanna (D) · Purchase · 2026-10-07Thomas H. Kean (R) · Sale (Partial) · 2026-09-17Pete Sessions (R) · Sale · 2026-10-02Gilbert Ray Cisneros (D) · Purchase · 2026-09-18Rick W. Allen (R) · Sale (Full) · 2026-07-13Rick W. Allen (R) · Sale · 2026-07-14Richard McCormick (R) · Sale · 2026-07-30Mike Kelly (R) · Sale · 2026-07-17Rick Larsen (D) · Sale · 2026-07-08Richard McCormick (R) · Purchase · 2026-06-12Ro Khanna (D) · Purchase · 2026-06-02Gilbert Ray Cisneros (D) · Purchase · 2026-06-16Julie Johnson (D) · Sale · 2026-05-12Gilbert Ray Cisneros (D) · Sale · 2026-05-15Rick W. Allen (R) · Sale · 2026-04-16Josh Gottheimer (D) · Sale · 2026-05-27Laura Friedman (D) · Exchange · 2026-03-24Michael T. McCaul (R) · Sale · 2026-03-04Richard McCormick (R) · Purchase · 2026-03-19Gilbert Ray Cisneros (D) · Sale · 2026-02-10Thomas H. Kean (R) · Purchase · 2026-01-29Ro Khanna (D) · Sale · 2026-01-22Ro Khanna (D) · Sale · 2026-01-22Ro Khanna (D) · Sale · 2026-01-23Ro Khanna (D) · Sale · 2026-01-29Julie Johnson (D) · Sale · 2025-12-18Julia Letlow (R) · Sale · 2025-12-08Gilbert Ray Cisneros (D) · Sale · 2025-12-19Byron Donalds (R) · Sale · 2025-12-04 Citadel Advisors · + $1095M · 2026-06-30Two Sigma Investments · + $746M · 2026-06-30Two Sigma Investments · OPENED $661M · 2026-03-31D.E. Shaw & Co. · + $554M · 2026-03-31Millennium Management · + $400M · 2026-06-30Citadel Advisors · + $392M · 2026-03-31AQR Capital Management · + $380M · 2026-06-30Citadel Advisors · + $308M · 2025-12-31Millennium Management · + $194M · 2026-03-31D.E. Shaw & Co. · + $169M · 2025-12-31D.E. Shaw & Co. · - $165M · 2026-06-30AQR Capital Management · OPENED $161M · 2026-03-31Point72 Asset Management · + $157M · 2026-06-30Millennium Management · + $155M · 2025-12-31 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
250 trading days · 29 congressional trades shown · 0 insider buys · 14 13F filings · 0 past bill actions · 5 upcoming markups

Executive Branch ConflictsABT held by Trump-administration officials

Lifetime Government AwardsABT federal contracts by year

$132M
total awarded · 2000–2013
1000
contracts on file
2013
peak year ($55M)
$55M $27M 2000: $862K across 1 contract $862K 2000 2005: $17K across 1 contract $17K 2005 2006: $99K across 3 contracts $99K 2006 3 contracts 2007: $1M across 14 contracts $1M 2007 14 contracts 2008: $2M across 19 contracts $2M 2008 19 contracts 2009: $5M across 24 contracts $5M 2009 24 contracts 2010: $11M across 46 contracts $11M 2010 46 contracts 2011: $21M across 112 contracts $21M 2011 112 contracts 2012: $36M across 421 contracts $36M 2012 421 contracts 2013: $55M across 359 contracts (peak year) $55M 2013 359 contracts
Top contracts by award amount
$8.6M Department of Veterans Affairs 2013-10-01 INTEGRATED CHEMISTRY AND IMMUNOASSAY TESTING ANALYZERS
$6.5M Department of Veterans Affairs 2013-10-01 IGF::OT::IGF - COST PER REPORTABLE TEST
$5.1M Department of Veterans Affairs 2013-07-01 MODIFICATION TO ADD ADDITIONAL TESTING AND PRICING.
$2.9M Department of Veterans Affairs 2012-10-01 CHEMISTRY - LABORATORY FOR VISN 15 FUNDING FOR REST OF BASE YEAR 01 OC
$2.9M Department of Veterans Affairs 2011-10-03 PROVIDE HEMOTOLOGY SERVICES TO ALL VISN 15 STATIONS BY ABBOTT
14 years · 1000 contracts

Smart Money · 13F HoldingsHedge funds holding ABT

$3.00B
Total ABT held by tracked 13F funds
9
Funds with ABT positions
Citadel Advisors $1.09B +216% 12 overlap 2026-06-30
Two Sigma Investments $746M +28% 12 overlap 2026-06-30
Millennium Management $400M +133% 12 overlap 2026-06-30
AQR Capital Management $380M +167% 12 overlap 2026-06-30
D.E. Shaw & Co. $165M -66% 12 overlap 2026-06-30
Point72 Asset Management $157M +467% 12 overlap 2026-06-30
Renaissance Technologies $45M -33% 9 overlap 2026-09-30
Bridgewater Associates $5M -49% 12 overlap 2026-06-30
1 more 13F positions tracked · quarterly delta charts available in member dashboard

Politicians Trading ABTMembers of Congress with recent ABT positions

21 politicians traded ABT across 98 disclosed transactions totaling $1.5M (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just ABT). 0-30 LOW · 30-60 MID · 60+ HIGH.
6 more politicians active in ABT · full table in member dashboard

Congressional TradesWho in Congress is trading ABT

2026-10-07 Ro Khanna D-California · house Purchase $15,001 - $50,000
2026-09-17 Thomas H. Kean R-New Jersey · house Sale (Partial) $1,001 - $15,000
2026-10-02 Pete Sessions R-Texas · house Sale $50,001 - $100,000
2026-09-18 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
2026-07-13 Rick W. Allen R-Georgia · house Sale (Full) $15,001 - $50,000
2026-07-14 Rick W. Allen R-Georgia · house Sale $15,001 - $50,000
2026-07-30 Richard McCormick R-Georgia · house Sale $1,001 - $15,000
2026-07-17 Mike Kelly R-Pennsylvania · house Sale $1,001 - $15,000
2026-07-08 Rick Larsen D-Washington · house Sale $1,001 - $15,000
2026-06-12 Richard McCormick R-Georgia · house Purchase $1,001 - $15,000
2026-06-02 Ro Khanna D-California · house Purchase $1,001 - $15,000
2026-06-16 Gilbert Ray Cisneros D-California · house Purchase $1,001 - $15,000
30+ trades on file · most recent 2026-11-05

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

2
option exercises · $21.5M
For ABT, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Bills Affecting ABTLive legislation impacting this stock

Political ProfileWhere ABT sits in Washington

bipartisan

Abbott moves on FDA device decisions, Medicare/Medicaid reimbursement changes, and formula-safety headlines, but its diversification dampens sensitivity to any single policy event.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • FDA device regulation and recalls
  • Medicaid drug price transparency
  • infant formula/FDA safety scrutiny
  • IVD/LDT diagnostic regulation
  • tariffs on medical imports

Regulatory opportunities

  • expanded CGM/diabetes device Medicare coverage
  • telehealth expansion
  • diagnostic reimbursement expansion
  • mental health access funding

LobbyingWho's hired to advocate for ABT

AdvaMedPhRMAMITAAmerican Clinical Laboratory Association
Member intelligence layer

Live signals + predictions for ABT — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout ABT & political exposure

Does Abbott Laboratories (ABT) hold federal contracts?
Yes. Abbott Laboratories has 5880 federal contract awards totaling $1,198,385,666, primarily from agencies including Department of Agriculture, Department of Commerce, Department of Defense. See full contract list and amounts on this page.
Which Trump cabinet officials own ABT stock?
2 Trump cabinet members or senior White House staff have disclosed holdings in ABT on their OGE 278 financial disclosures, including Donald J. Trump, Jamieson Greer. See the Cabinet Conflicts panel for details.
Has Congress traded ABT stock?
527 congressional trades by 54 unique members of Congress, most recently on 2026-10-07. See the Congressional Trading panel for politician-by-politician breakdown.
What is ABT political risk profile?
Government dependence: 55/100. Lobbying intensity: 35/100. Political signal: medium. Donor party split: bipartisan.
How does GovGreed track ABT political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. ABT data is updated daily from these official federal sources.